Slovenia-Switzerland Bilateral Trade Analysis 2023

Complete trade statistics: $25.35B total volume โ€ขSlovenia surplus: $2.80B

Slovenia โ†’ Switzerland

$14.08B

Exports (2023)

Switzerland โ†’ Slovenia

$11.27B

Imports (2023)

Trade Balance

$2.80B

Surplus for Slovenia

Total Trade

$25.35B

Combined Volume

Trade Flow Visualization

Direct trade relationship between Slovenia and Switzerland. Green line shows exports from Slovenia, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Slovenia-Switzerland commercial relationship and competitive positioning in global markets.

Slovenia โ†’ Switzerland Exports

$14.08B
2023 Total

Export Market Intelligence

Product Diversity:
Highly Diversified
Market Share:
91.4% top product
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$12.87B
91.4% of exports
2Heterocyclic compounds: n.e.c. in headings no. 2933
$316.09M
2.2% of exports
3Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$148.35M
1.1% of exports
4Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale
$56.12M
0.4% of exports
5Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5
$46.67M
0.3% of exports
6Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale
$41.16M
0.3% of exports
7Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)
$28.58M
0.2% of exports
8Buildings: prefabricated, not of wood
$25.76M
0.2% of exports
9Vehicles: with only compression-ignition internal combustion piston engine (diesel or semi-diesel), cylinder capacity over 1500 but not over 2500cc
$22.63M
0.2% of exports
10Meat and edible offal: of fowls of the species Gallus domesticus, cuts and offal, fresh or chilled
$15.67M
0.1% of exports

๐ŸŽฏ Strategic Export Focus

Slovenia's export portfolio to Switzerland demonstrates strong diversification across multiple sectors, with medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale representing a key competitive advantage in this bilateral market.

Switzerland โ†’ Slovenia Imports

$11.27B
2023 Total

Import Dependency Profile

Supply Diversity:
Well Diversified
Critical Imports:
49.4% concentration
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$5.57B
49.4% of imports
2Heterocyclic compounds: with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivatives
$1.76B
15.6% of imports
3Heterocyclic compounds: n.e.c. in headings no. 2933
$1.01B
8.9% of imports
4Sulphonamides: n.e.c. in heading no. 2935
$973.34M
8.6% of imports
5Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5
$834.77M
7.4% of imports
6Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$450.05M
4.0% of imports
7Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale
$253.90M
2.3% of imports
8Metals: gold, non-monetary, unwrought (but not powder)
$50.03M
0.4% of imports
9Metals: gold, semi-manufactured
$30.09M
0.3% of imports
10Wrist-watches: whether or not incorporating a stop-watch facility, with automatic winding
$20.51M
0.2% of imports

๐Ÿ“ฆ Import Strategy Analysis

Slovenia's import pattern from Switzerland reveals strategic sourcingin medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

๐Ÿ†

Market Leadership

Slovenia demonstrates competitive strength in exportingmedicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale to Switzerland, leveraging comparative advantages.

Export Leader in 20+ Categories
๐Ÿ”„

Trade Complementarity

The bilateral relationship showsstrongcomplementarity, with each country specializing in different sectors.

Highly Balanced
๐Ÿ“ˆ

Growth Potential

The $25.35B trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Major Partnership

Executive Summary: Slovenia-Switzerland Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $25.35 billionrepresenting a significant bilateral economic relationship
  • Trade Balance: Slovenia maintains a surplus of $2.80 billion
  • Export Focus: Slovenia's primary exports include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, heterocyclic compounds: n.e.c. in headings no. 2933, blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
  • Import Dependencies: Key imports from Switzerland include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, heterocyclic compounds: with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivatives, heterocyclic compounds: n.e.c. in headings no. 2933

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationDiversified
Trade Balance HealthBalanced

๐Ÿ“ˆ Market Position: This bilateral trade relationship represents a significant global trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $25.35B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with Slovenia leveraging its comparative advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

Slovenia's specialization in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail salecomplements Switzerland's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $25.35B bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationLow
Market DependencyModerate
๐Ÿ”ฎ

Trade Relationship Outlook

The $25.35B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

๐Ÿ’ฐ

Trade Volume Impact

The $25.35 billion bilateral trade volume represents a significant economic factorfor both economies.

Economic Significance: High
๐Ÿญ

Industrial Integration

Trade flows in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale and medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Diversified
โš–๏ธ

Trade Balance Effects

Slovenia's trade surplus of $2.80 billion strengthens its overall economic position in this bilateral relationship.

Balance Impact: Well Balanced

Strategic Future Outlook

๐Ÿš€Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in heterocyclic compounds: n.e.c. in headings no. 2933 present expansion opportunities.
Market Diversification
Beyond current focus on medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, new product categories offer potential for trade expansion.

โš ๏ธRisk Factors

Supply Chain Vulnerabilities
Moderate concentration in key sectors requires monitoring
Market Competition
Global competition in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale may affect future market positioning.

๐ŸŽฏStrategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between Slovenia and Switzerland represents a total trade volume of $25.35 billion in 2023. This partnership demonstrates a favorable trade balance for Slovenia, with exports exceeding importsby $2.80 billion.

Export Strengths

Slovenia's exports to Switzerland total $14.08 billion, with competitive advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, representing $12.87B or91.4% of bilateral exports.

Import Dependencies

Imports from Switzerland amount to $11.27 billion, highlighting economic interdependence in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, with Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale comprising49.4% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade surplus indicates Slovenia's competitive position in this bilateral relationship. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between Slovenia and Switzerland in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) โ€ข Last Updated: January 2025 โ€ข Coverage: 1995-2023